Recruiting studies: Infection In Solid Organ Transplant Recipients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT06986980 Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Phase N/A · 23 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05234723 Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Phase N/A · 27 location(s) · Arkansas Children's Hospital Research Institute · NCT05550298 Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675 Factors Affecting Vaccine Prophylaxis Efficacy in Bone Marrow and Solid Organ Transplant Recipients: Impact on Infection
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07473999 Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Phase 4 · 1 location(s) · Tufts Medical Center · NCT05626530 Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04579471 Study Evaluating the Efficacy and Safety of Artesunate
Phase 2 · 4 location(s) · Amivas Inc. · NCT06853184 High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05947071 A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and th
Phase 2 · 37 location(s) · GlaxoSmithKline · NCT07092865 COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2 · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06599658 Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.